Visilizumab, CAS 219716-33-3

Product Description: Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Qi T Yu, et al. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways. Clin Immunol. 2008 Jun;127(3):322-9.

CAS Number: 219716-33-3

Molecular Weight: N/A

Compound Purity: 99.49

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Apoptosis

• SKU: MEXHY-P99332-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99332-1
• Green Labware: No
• Package Unit: 1 mg
• Quantity Unit: STK